These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31908294)

  • 21. High-dose chemotherapy for breast cancer: is another look warranted?
    Nieto Y; Jones RB; Shpall EJ
    Curr Opin Oncol; 2004 Mar; 16(2):114-9. PubMed ID: 15075901
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are anthracycline-taxane regimens the new standard of care in the treatment of metastatic breast cancer?
    Valero V; Hortobagyi GN
    J Clin Oncol; 2003 Mar; 21(6):959-62. PubMed ID: 12637456
    [No Abstract]   [Full Text] [Related]  

  • 23. Adjuvant therapy for breast cancer.
    Budman DR; Citron ML
    Clin Obstet Gynecol; 1994 Dec; 37(4):978-87. PubMed ID: 7842566
    [No Abstract]   [Full Text] [Related]  

  • 24. Carboplatin and etoposide in metastatic breast cancer.
    Crown J; Hamilton N; Raptis G; Kritz A; Vahdat L; Norton L
    Ann Oncol; 1995 Apr; 6(4):403. PubMed ID: 7619757
    [No Abstract]   [Full Text] [Related]  

  • 25. Breast cancer: metastatic.
    Johnston S; Stebbing J
    Clin Evid; 2002 Jun; (7):1579-602. PubMed ID: 12230774
    [No Abstract]   [Full Text] [Related]  

  • 26. A meta-analysis of randomized controlled trials comparing chemotherapy plus trastuzumab with chemotherapy alone in HER-2-positive advanced breast cancer.
    Liao C; Yin F; Huang P; Cao Y; Gao F
    Breast J; 2011; 17(1):109-11. PubMed ID: 21129096
    [No Abstract]   [Full Text] [Related]  

  • 27. Single agent versus combination chemotherapy for metastatic breast cancer.
    Carrick S; Parker S; Wilcken N; Ghersi D; Marzo M; Simes J
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003372. PubMed ID: 15846660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant therapy for all patients with breast cancer?
    Lippman ME; Hayes DF
    J Natl Cancer Inst; 2001 Jan; 93(2):80-2. PubMed ID: 11208870
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials.
    Atalay G; Biganzoli L; Renard F; Paridaens R; Cufer T; Coleman R; Calvert AH; Gamucci T; Minisini A; Therasse P; Piccart MJ;
    Eur J Cancer; 2003 Nov; 39(17):2439-49. PubMed ID: 14602130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination chemotherapy for metastatic breast cancer: reaching for the cure.
    Overmoyer B
    J Clin Oncol; 2003 Feb; 21(4):580-2. PubMed ID: 12586790
    [No Abstract]   [Full Text] [Related]  

  • 31. Re: Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.
    Powles TJ
    J Natl Cancer Inst; 2000 Dec; 92(24):2040-2. PubMed ID: 11121468
    [No Abstract]   [Full Text] [Related]  

  • 32. High-dose chemotherapy in high-risk breast cancer.
    Price LA
    Lancet; 1998 Nov; 352(9139):1551-2. PubMed ID: 9820326
    [No Abstract]   [Full Text] [Related]  

  • 33. [Doxorubicin and paclitaxel versus 5-fluorouracil, doxorubicin and cyclophosphamide as first-line treatment in women with metastatic breast carcinoma: final results of a phase III multicenter randomized trial].
    Amadori D; Fabbri M
    Tumori; 2001; 87(5):A18-9. PubMed ID: 11765729
    [No Abstract]   [Full Text] [Related]  

  • 34. [The optimal duration of adjuvant therapy in breast cancer: what kind of evidence? Chemotherapy: the example of clinical studies].
    Sdrobolini A
    Suppl Tumori; 2004; 3(4):S77-8. PubMed ID: 15206220
    [No Abstract]   [Full Text] [Related]  

  • 35. Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled Trials.
    Cao L; Yao GY; Liu MF; Chen LJ; Hu XL; Ye CS
    PLoS One; 2015; 10(12):e0145442. PubMed ID: 26717149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of locally advanced breast cancer.
    Verma S; Clemons M; Fitzgerald B; Freedman O
    CMAJ; 2004 Aug; 171(3):219; author reply 221-2. PubMed ID: 15289404
    [No Abstract]   [Full Text] [Related]  

  • 37. Issues in the chemotherapy of breast cancer.
    de Graaf H; Willemse PH; de Vries EG; Mulder NH
    Neth J Med; 1998 Sep; 53(3):97-108. PubMed ID: 9803140
    [No Abstract]   [Full Text] [Related]  

  • 38. Re: International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
    Chlebowski RT
    J Natl Cancer Inst; 2010 Jan; 102(2):137. PubMed ID: 20019336
    [No Abstract]   [Full Text] [Related]  

  • 39. Standard medical treatment for early breast cancer.
    Lohrisch C; Piccart MJ
    Eur J Cancer; 2001 Oct; 37 Suppl 7():S45-58. PubMed ID: 11888004
    [No Abstract]   [Full Text] [Related]  

  • 40. Re: Polychemotherapy for early breast cancer: results from the international adjuvant breast cancer chemotherapy randomized Trial.
    Ferretti G; Felici A; Carlini P; Cognetti F
    J Natl Cancer Inst; 2007 Sep; 99(18):1416. PubMed ID: 17848675
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.